Standard InChI: InChI=1S/C22H18N4O4/c23-19(24)13-5-9-17(10-6-13)29-21(27)15-1-2-16(4-3-15)22(28)30-18-11-7-14(8-12-18)20(25)26/h1-12H,(H3,23,24)(H3,25,26)
Standard InChI Key: CTQZULQMEBBXGY-UHFFFAOYSA-N
Associated Targets(Human)
A549 127892 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
MCF7 126967 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
SF-268 49410 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
NCI-H460 60772 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Associated Targets(non-human)
Pneumocystis carinii 749 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
DNA 1199 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Glutamate NMDA receptor 6467 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Molecule Features
Natural Product: No
Oral: No
Chemical Probe: No
Parenteral: No
Molecule Type: Small molecule
Topical: No
First In Class: No
Black Box: No
Chirality: No
Availability: No
Prodrug: No
Drug Indications
MESH ID
MESH Heading
EFO IDs
EFO Terms
Max Phase for Indication
References
Mechanisms of Action
Mechanism of Action
Action Type
target ID
Target Name
Target Type
Target Organism
Binding Site Name
References
Properties
Molecular Weight: 402.41
Molecular Weight (Monoisotopic): 402.1328
AlogP: 2.69
#Rotatable Bonds: 6
Polar Surface Area: 152.34
Molecular Species: BASE
HBA: 6
HBD: 4
#RO5 Violations: 0
HBA (Lipinski): 8
HBD (Lipinski): 6
#RO5 Violations (Lipinski): 1
CX Acidic pKa:
CX Basic pKa: 11.83
CX LogP: 3.14
CX LogD: -1.68
Aromatic Rings: 3
Heavy Atoms: 30
QED Weighted: 0.22
Np Likeness Score: -0.08
References
1.Vanden Eynde JJ, Mayence A, Huang TL, Collins MS, Rebholz S, Walzer PD, Cushion MT.. (2004) Novel bisbenzamidines as potential drug candidates for the treatment of Pneumocystis carinii pneumonia., 14 (17):[PMID:15357989][10.1016/j.bmcl.2004.06.034]
2.Vanden Eynde JJ, Mayence A, Johnson MT, Huang TL, Collins MS, Rebholz S, Walzer PD, Cushion MT, Donkor IO. (2005) Antitumor and Anti-Pneumocystis Carinii Activities of Novel Bisbenzamidines, 14 (3):[10.1007/s00044-005-0130-2]
3.Berger ML, Maciejewska D, Vanden Eynde JJ, Mottamal M, Żabiński J, Kaźmierczak P, Rezler M, Jarak I, Piantanida I, Karminski-Zamola G, Mayence A, Rebernik P, Kumar A, Ismail MA, Boykin DW, Huang TL.. (2015) Pentamidine analogs as inhibitors of [(3)H]MK-801 and [(3)H]ifenprodil binding to rat brain NMDA receptors., 23 (15):[PMID:26117647][10.1016/j.bmc.2015.06.012]